Skip to main content
. 2007 Dec;12(4):299–306. doi: 10.1379/CSC-270.1

Fig 1.

Fig 1.

Pentosidine levels in urine and plasma from diabetic patients. (A) Urine and (B) plasma samples from patients with nephropathy secondary to type 2 diabetes and age-matched controls were assayed for pentosidine by high-performance liquid chromatography, as described in Materials and Methods. Data are expressed as mean ± standard error of mean of 3 independent analyses on 16– 21 patients per group. **P < 0.01 vs controls; C, controls; DN, type 2 diabetic patients with nephropathy